The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons
Open accessAbstract
The brain of Down syndrome (DS) patients exhibits fewer interneurons in the cerebral cortex, but its underlying mechanism remains unknown. By morphometric analysis of cortical interneurons generated from DS and euploid induced pluripotent stem cells (iPSCs), we found that DS GABA neurons are smaller and with fewer neuronal processes. The proportion of calretinin over calbindin GABA neurons is reduced, and the neuronal migration capacity is decreased. Such phenotypes were replicated following transplantation of the DS GABAergic progenitors into the mouse medial septum. Gene expression profiling revealed altered cell migratory pathways, and correction of the PAK1 pathway mitigated the cell migration deficit in vitro. These results suggest that impaired migration of DS GABAergic neurons may contribute to the reduced number of interneurons in the cerebral cortex and hippocampus in DS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Evidence from iPSCs differentiated to ventral forebrain-like interneuron progenitors indicates that the number of progenitors that are produced is different in the presence of T21 (84,90,91).”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [90]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human cortical interneurons have been shown to integrate extensively into the host mouse brain thanks to the remarkable migratory properties of this class of neurons”
From Xenotransplanted human cortical neurons reveal species-specific development and functional integration into mouse visual circuits (2019) · cites this paper as Huo et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, interneuron progenitors from T21 iPSCs show reduced migratory ability90 compared to controls, raising the likelihood that defects in specification, proliferation and/or migration together result in deficiency of interneurons in DS.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, interneuron progenitors from T21 iPSCs show reduced migratory ability90 compared to controls, raising the likelihood that defects in specification, proliferation and/or migration together result in deficiency of interneurons in DS.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“However, another study using a 2D culture method identified a significant decrease in calretinin positive interneurons along with a significant decrease in calbindin positive interneurons (Huo et al., 2018).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Huo et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GABAergic cell subtypes and their synaptic connections in rat frontal cortex
Kawaguchi, Y. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.6.476 · Cited by 1,416
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
The origin and specification of cortical interneurons
Wonders, C. P., & Anderson, S. A. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1954 · Cited by 980 · cited 1×
“They may be subdivided into multiple subtypes according to the expression of calbindin (CB), SST, CR, and parvalbumin (PV) (Kawaguchi and Kubota, 1997; Wonders and Anderson, 2006).”
BackgroundMosaic Organization of Neural Stem Cells in the Adult Brain
Merkle, F. T., Mirzadeh, Z., & Álvarez-Buylla, A. (2007) · Science · doi:10.1126/science.1144914 · Cited by 821
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Synaptic dysregulation in a human iPS cell model of mental disorders
Wen, Z., Nguyen, H. N., Guo, Z., Lalli, M. A., Wang, X., Su, Y., Kim, N.-S., Yoon, K.-J., Shin, J., Zhang, C., et al. (2014) · Nature · doi:10.1038/nature13716 · Cited by 549
Subcortical origins of human and monkey neocortical interneurons
Ma, T., Wang, C., Wang, L., Zhou, X., Tian, M., Zhang, Q., Zhang, Y., Li, J., Liu, Z., Cai, Y., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3536 · Cited by 322
Self-citationModeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons
Chen, H., Qian, K., Du, Z., Cao, J., Petersen, A., Liu, H., Blackbourn, L. W., Huang, C.-L., Errigo, A., Yin, Y., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.004 · Cited by 318
Self-citationA Human Stem Cell Model of Early Alzheimer’s Disease Pathology in Down Syndrome
Shi, Y., Kirwan, P., Smith, J., MacLean, G., Orkin, S. H., & Livesey, F. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003771 · Cited by 310
Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells
Liu, Y., Liu, H., Sauvey, C., Yao, L., Żarnowska, E. D., & Zhang, S. (2013) · Nature Protocols · doi:10.1038/nprot.2013.106 · Cited by 308
Self-citation
Cited by
Sorted by citations
Linaro, D., Vermaercke, B., Iwata, R., Ramaswamy, A., Davis, B. A., Boubakar, L., Libé-Philippot, B., Bilheu, A., Bruyne, L. D., Gall, D., et al. (2019) · doi:10.1101/626218 · Cited by 210
“Human cortical interneurons have been shown to integrate extensively into the host mouse brain thanks to the remarkable migratory properties of this class of neurons (Cunningham et al., 2014; Fandel et al., 2016; Huo et al., 2018; Noakes et al., 2019; Southwell et al., 2014).”
BackgroundXu, R., Brawner, A. T., Li, S., Liu, J.-J., Kim, H., Xue, H., Pang, Z. P., Kim, W.-Y., Hart, R. P., Liu, Y., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.014 · Cited by 193
Self-citationHuman Models Are Needed for Studying Human Neurodevelopmental Disorders
Zhao, X., & Bhattacharyya, A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.009 · Cited by 192
Self-citationTang, X.-Y., Xu, L., Wang, J., Hong, Y., Wang, Y., Zhu, Q., Wang, D., Zhang, X.-Y., Liu, C.-Y., Fang, K.-H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135763 · Cited by 143
Self-citationIn vivo modeling of human neuron dynamics and Down syndrome
Real, R., Peter, M., Trabalza, A., Khan, S., Smith, M. A., Dopp, J., Barnes, S. J., Momoh, A., Strano, A., Volpi, E., et al. (2018) · Science · doi:10.1126/science.aau1810 · Cited by 120
Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 143
Human cerebral organoids establish subcortical projections in the mouse brain after transplantation
Dong, X., Xu, S., Chen, X., Tao, M., Tang, X.-Y., Fang, K.-H., Xu, M., Pan, Y., Chen, Y., He, S., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00910-4 · Cited by 121
Self-citationDown-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors
Meharena, H. S., Marco, A., Dileep, V., Lockshin, E. R., Akatsu, G. Y., Mullahoo, J., Watson, L. A., Ko, T., Guerin, L. N., Abdurrob, F., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2021.12.002 · Cited by 92
Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
Silva, M. C., & Haggarty, S. J. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14012 · Cited by 88
Mizuno, G. O., Wang, Y., Shi, G., Wang, Y., Sun, J., Papadopoulos, S., Broussard, G. J., Unger, E. K., Deng, W., Weick, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.033 · Cited by 58
Self-citationSobol, M., Klar, J., Laan, L., Shahsavani, M., Schuster, J., Annerén, G., Konzer, A., Mi, J., Bergquist, J., Nordlund, J., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1585-3 · Cited by 61
Foliaki, S. T., Schwarz, B. H., Groveman, B. R., Walters, R. O., Ferreira, N., Orru, C. D., Smith, A., Wood, A. R., Schmit, O. M., Freitag, P., et al. (2021) · Molecular Brain · doi:10.1186/s13041-021-00864-w · Cited by 59
Interneuron development and dysfunction
Yang, J., Yang, X. W., & Tang, K. (2021) · FEBS Journal · doi:10.1111/febs.15872 · Cited by 54
Ponroy Bally, B., Farmer, W. T., Jones, E. V., Jessa, S., Kacerovsky, J. B., Mayran, A., Peng, H., Lefebvre, J. L., Drouin, J., Hayer, A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa003 · Cited by 49
Neurodevelopment in Down syndrome: Concordance in humans and models
Klein, J. A., & Haydar, T. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.941855 · Cited by 47
“However, another study using a 2D culture method identified a significant decrease in calretinin positive interneurons along with a significant decrease in calbindin positive interneurons (Huo et al., 2018).”
BackgroundUtami, K. H., Skotte, N. H., Colaço, A. R., Yusof, N. A. B. M., Sim, B., Yeo, X. Y., Bae, H.-G., Garcia-Miralles, M., Radulescu, C. I., Chen, Q., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.005 · Cited by 47
Modeling human neurodevelopmental diseases with brain organoids
Lu, X., Yang, J., & Xiang, Y. (2022) · Cell Regeneration · doi:10.1186/s13619-021-00103-6 · Cited by 50
Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease
Martinez, J. L., Zammit, M. D., West, N. R., Christian, B. T., & Bhattacharyya, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.703876 · Cited by 47
Self-citationBioengineering tissue morphogenesis and function in human neural organoids
Fedorchak, N. J., Iyer, N. R., & Ashton, R. S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.05.025 · Cited by 41
Pecze, L., Randi, E. B., & Szabó, C. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00225-8 · Cited by 43
Liaci, C., Camera, M., Caslini, G., Rando, S., Contino, S., Romano, V., & Merlo, G. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116167 · Cited by 40
Altered patterning of trisomy 21 interneuron progenitors
Giffin-Rao, Y., Sheng, J., Strand, B., Xu, K., Huang, L., Medo, M., Risgaard, K. A., Dantinne, S., Mohan, S., Keshan, A., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.001 · Cited by 38
Self-citationDi-(2-ethylhexyl) phthalate exposure impairs cortical development in hESC-derived cerebral organoids
Yang, L., Zou, J., Zang, Z., Wang, L., Du, Z., Zhang, D., Cai, Y., Li, M., Li, Q., Gao, J., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.161251 · Cited by 36
Astrocytes in Down Syndrome Across the Lifespan
Ponroy Bally, B., & Murai, K. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.702685 · Cited by 35
Murray, A., Gough, G., Cindrić, A., Vučković, F., Koschut, D., Borelli, V., Petrović, D. J., Bekavac, A., Plećaš, A., Hribljan, V., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104692 · Cited by 38
Wu, C.-I., Vinton, E. A., Pearse, R. V., Heo, K., Aylward, A. J., Hsieh, Y., Bi, Y., Adeleye, S., Fancher, S. B., Duong, D. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01454-5 · Cited by 34
Chi, C., Knight, W. E., Riching, A. S., Zhang, Z., Tatavosian, R., Zhuang, Y., Moldovan, R., Rachubinski, A. L., Gao, D., Xu, H., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107012 · Cited by 30
Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome
Rueda, N., Flórez, J., Dierssen, M., & Martínez‐Cué, C. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.001 · Cited by 30
Abnormal mitochondria in Down syndrome iPSC-derived GABAergic interneurons and organoids
Xu, L., Huo, H.-Q., Lu, K., Tang, X.-Y., Hong, Y., Han, X., Fu, Z., Fang, K.-H., Xu, M., Guo, X. L., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166388 · Cited by 33
Self-citationChoroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2
Shaker, M. R., Slonchak, A., Al-mhanawi, B., Morrison, S. D., Sng, J. D. J., Cooper-White, J. J., Khromykh, A. A., & Wolvetang, E. J. (2024) · Science Advances · doi:10.1126/sciadv.adj4735 · Cited by 34
Consequences of trisomy 21 for brain development in Down syndrome
Russo, M. L., Sousa, A. M. M., & Bhattacharyya, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00866-2 · Cited by 28
“…and matched lines of trisomic organoids differentiated to produce neurons with a ventral forebrain fate 91 , whereas other studies have shown a significant decrease in calretinin-expressing interneurons that was concomitant with a significant decrease in calbindin-expressing interneurons 84,90 .”
InfluentialSelf-citationAhmed, M. M., Wang, A. C., Elos, M. T., Chial, H. J., Sillau, S., Solano, D. A., Coughlan, C. M., Aghili, L., Anton, P. E., Markham, N. E., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105694 · Cited by 31
Rastogi, M., Bartolucci, M., Nanni, M., Aloisio, M., Vozzi, D., Petretto, A., Contestabile, A., & Cancedda, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.002 · Cited by 26
Neuroanatomical alterations in higher-order thalamic nuclei of fetuses with Down syndrome
Stagni, F., Giacomini, A., Emili, M., Uguagliati, B., Bonasoni, M. P., Bartesaghi, R., & Guidi, S. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.105870 · Cited by 26
Brain circuit pathology in Down syndrome: from neurons to neural networks
Bartesaghi, R. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0067 · Cited by 25
Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome
Li, Z., Klein, J. A., Rampam, S., Kurzion, R., Campbell, N. B., Patel, Y., Haydar, T. F., & Zeldich, E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.932384 · Cited by 24
Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome
Lee, S. E., Duran-Martinez, M., Khantsis, S., Bianchi, D. W., & Guedj, F. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.10.001 · Cited by 25
Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome
Botté, A., & Potier, M. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.002 · Cited by 22
Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome
Utagawa, E. C., Moreno, D. G., Schafernak, K. T., Arva, N. C., Malek‐Ahmadi, M. H., Mufson, E. J., & Perez, S. E. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01385-w · Cited by 24
Dufour, B. D., McBride, E., Bartley, T., Juárez, P., & Martínez‐Cerdeño, V. (2023) · Autism · doi:10.1177/13623613231154053 · Cited by 23
Mitsogiannis, M. D., Pancho, A., Aerts, T., Sachse, S., Vanlaer, R., Noterdaeme, L., Schmucker, D., & Seuntjens, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.624181 · Cited by 22
Modeling Down syndrome in cells: From stem cells to organoids
Gough, G., O’Brien, N. L., Alić, I., Goh, P. A., Yeap, Y. J., Groet, J., Nižetić, D., & Murray, A. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.003 · Cited by 21
Prem, S., Dev, B., Peng, C., Mehta, M., Alibutud, R., Connacher, R., Thomas, M. S., Zhou, X., Matteson, P. G., Xing, J., et al. (2024) · eLife · doi:10.7554/elife.82809 · Cited by 19
Guerreiro, S. R., & Maciel, P. (2023) · Cells · doi:10.3390/cells12040538 · Cited by 20
Kalra, R. S., Dhanjal, J. K., Das, M., Singh, B., & Naithani, R. (2021) · Cells · doi:10.3390/cells10102558 · Cited by 18
Cell models for Down syndrome-Alzheimer’s disease research
Wu, Y., West, N. R., Bhattacharyya, A., & Wiseman, F. K. (2022) · Neuronal Signaling · doi:10.1042/ns20210054 · Cited by 17
Self-citationChen, C., Lan, Z., Tang, X., Chen, W., Zhou, X. W., Su, H., Su, R., Chen, Z., Chen, H., Guo, Y., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27001 · Cited by 16
A Tale of Two Chimeras: Applying the Six Principles to Human Brain Organoid Xenotransplantation
Barnhart, A. J., & Dierickx, K. (2023) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180123000051 · Cited by 16
Transcriptional consequences of trisomy 21 on neural induction
Martinez, J. L., Piciw, J. G., Crockett, M., Sorci, I. A., Makwana, N., Sirois, C. L., Giffin-Rao, Y., & Bhattacharyya, A. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1341141 · Cited by 15
Self-citationPapetti, A. V., Jin, M., Ma, Z., Stillitano, A. C., & Jiang, P. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.036 · Cited by 15
Bartesaghi, R., Vicari, S., & Mobley, W. C. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-041521-103641 · Cited by 18
Czerminski, J. T., King, O. D., & Lawrence, J. B. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.972201 · Cited by 16
Watson, L. A., & Meharena, H. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1198129 · Cited by 13
Karampatsi, D., Zabala, A., Wilhelmsson, U., Dekens, D. W., Vercalsteren, E., Larsson, M., Nyström, T., Pekny, M., Patrone, C., & Darsalia, V. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01426-z · Cited by 13
Neurodevelopmental wiring deficits in the Ts65Dn mouse model of Down syndrome
Jain, S., Watts, C. A., Chung, W. C. J., & Welshhans, K. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134569 · Cited by 13
Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain
Farley, S. J., Grishok, A., & Zeldich, E. (2022) · Epigenetics & Chromatin · doi:10.1186/s13072-022-00471-6 · Cited by 13
Nicholson, R., Osborne, D., Fairhead, L., Beed, L., Hill, C. M., & Lee, H. (2022) · Eye · doi:10.1038/s41433-021-01883-6 · Cited by 10
Rusu, B., Kukreja, B., Wu, T., Dan, S. J., Feng, M. Y., & Kalish, B. T. (2023) · eNeuro · doi:10.1523/eneuro.0147-23.2023 · Cited by 9
Zhao, Y., Liu, P., Wang, Y., Ma, Y., Guo, W., & Shi, C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114848 · Cited by 11
Dong, X., Yang, L., Liu, K., Ji, X., Tang, C., Li, W., Ma, L., Mei, Y., Peng, T., Feng, B., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108802 · Cited by 9
Self-citationMazzarino, R. C., Barešová, V., Zikánová, M., Duval, N., Wilkinson, T. G., Patterson, D., & Vacano, G. N. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247227 · Cited by 8
Liu, H., Huang, S., Wang, W., Wang, H., Huang, W., Zhai, Z., Wang, D., Fan, Y., Sun, J., Li, D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05481-6 · Cited by 8
Dosage Counts: Correcting Trisomy-21-Related Phenotypes in Human Organoids and Xenografts
Manley, W. F., & Anderson, S. A. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.009 · Cited by 7
Lee, S. E., Baxter, L. L., Duran, M. I., Morris, S. D., Mosley, I. A., Fuentes, K., Pennings, J. L. A., Guedj, F., & Bianchi, D. W. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae160 · Cited by 7
Pereira, M. F., Shyti, R., & Testa, G. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.05.004 · Cited by 8
Integrative Analysis Extracts a Core ceRNA Network of the Fetal Hippocampus With Down Syndrome
Wang, S., Tang, X., Qin, L., Shi, W., Bian, S., Wang, Z., Wang, Q., Wang, X., Gu, J., Hao, B., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.565955 · Cited by 6
Ji, Y., McLean, J. L., & Xu, R. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01189-z · Cited by 8
Wang, Y., Li, Z., Yang, G., Cai, L., Yang, F., Zhang, Y., Zeng, Y., Ma, Q., & Zeng, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.661381 · Cited by 6
López‐Hidalgo, R., Ballestín, R., Lorenzo, L., Sánchez-Martí, S., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105679 · Cited by 6
iPSCs-Derived Neurons and Brain Organoids from Patients
Zhu, W., Xu, L., Li, X., Hu, H., Lou, S.-N., & Liu, Y. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_657 · Cited by 5
Self-citationStem cell-based therapeutic strategies for down syndrome and Alzheimer’s disease
Hamadelseed, O., & Skutella, T. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04556-3 · Cited by 5
Martínez, A. L., Brea, J. M., Domínguez, E., Varela, M. J., Allegue, C., Cruz, R., Monroy, X., Merlos, M., Burgueño, J., Carracedo, Á., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.816325 · Cited by 5
Muza, P. M., Bush, D., Pérez-González, M., Zouhair, I., Cleverley, K., Sopeña, M. L., Aoidi, R., West, S. J., Good, M. A., Tybulewicz, V. L. J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106073 · Cited by 6
Ahmed, M. M., Wang, A. C.-J., Elos, M. T., Chial, H. J., Sillau, S. H., Solano, D., Coughlan, C. M., Aghili, L., Anton, P., Markham, N., et al. (2021) · bioRxiv · doi:10.1101/2021.07.04.451073 · Cited by 2
Trisomy 21-driven metabolite alterations are linked to cellular injuries in Down syndrome
Liu, J., Chen, S., Huang, G., Wen, P., Zhou, X., & Wu, Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05127-0 · Cited by 4
Cindrić, A., Vučković, F., Murray, A., Klarić, T., Alić, I., Petrović, D. J., Krištić, J., Nižetić, D., & Lauc, G. (2024) · BBA Advances · doi:10.1016/j.bbadva.2024.100137 · Cited by 4
Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells
Saito, M. K. (2021) · Children · doi:10.3390/children8020094 · Cited by 4
Niu, R., Xue, L., Tian, X., Huangfu, L., Chen, L., Zhai, C.-Y., Wang, S., Zhao, Y., Gan, Z., Qin, H.-Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66109-9 · Cited by 3
Xiong, Y., Li, L., & Zhang, X. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1575348 · Cited by 4
Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome
Emili, M., Stagni, F., Bonasoni, M., Guidi, S., & Bartesaghi, R. (2024) · Developmental Neurobiology · doi:10.1002/dneu.22953 · Cited by 3
Berden, L., Rajan, N., Mfossa, A. C. M., Bie, I. D., Etlioglu, E., Benotmane, M. A., Verslegers, M., Aourz, N., Smolders, I. J., Rigo, J., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05643-7 · Cited by 3
Hinckelmann, M.-V., Dubos, A., Artot, V., Rudolf, G., Nguyen, T. L., Tilly, P., Nalesso, V., Moreno, M. D. M. M., Birling, M., Godin, J. D., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03109-7 · Cited by 4
Tan, R., Wen, Z., He, X., Lu, B., Hu, E., Xie, R., Lan, G., Guo, C., Cheng, C., Cheng, B., et al. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125355 · Cited by 2
Barraza, N., Pérez-Núñez, R., Gaete‐Ramírez, B., Barrios-Garrido, A., Arriagada, C., Poksay, K. S., John, V., Barnier, J., Cárdenas, A. M., & Caviedes, P. A. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00638-3 · Cited by 2
A Dive Into Cerebellar Dysfunction, Motor Deficits and GABAergic Signaling in Down Syndrome
Feely, S., Rodriguez, M. R., Shannon, A., Young, S., Rosales, J. P., & Kaur, G. (2025) · Cureus · doi:10.7759/cureus.79623 · Cited by 2
Hanics, J., Tretiakov, E. O., Romanov, R. A., Gáspárdy, A., Hevesi, Z., Schnell, R., Harkany, T., & Alpár, A. (2025) · Acta Physiologica · doi:10.1111/apha.70031 · Cited by 2
Modeling Down syndrome neurodevelopment with isogenic cerebral organoidsPreprint
Czerminski, J. T., King, O. D., & Lawrence, J. B. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.25.493459 · Cited by 2
Hinckelmann, M.-V., Dubos, A., Artot, V., Rudolf, G., Nguyen, T. L., Tilly, P., Nalesso, V., Moreno, M. D. M. M., Birling, M., Godin, J. D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.09.566424 · Cited by 2
Yu, Y., Alonzo, M., Ye, S., Fang, A., Manickam, K., Garg, V., & Zhao, M. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103155 · Cited by 1
REST deficiency and neurogenic-to-gliogenic shift in down syndrome human cerebral organoids
Huang, T., Lim, C.-T., Li, W., Fakurazi, S., Mason, J. O., Cheah, P.-S., Li, Y., & Ling, K. (2026) · Molecular Brain · doi:10.1186/s13041-026-01313-2 · Cited by 1
Plećaš, A., Gough, G., Grčević, D., Jackowiak, H., Skieresz‐Szewczyk, K., Horaček, M., Šimunić, I., Krsnik, Ž., Mitrečić, D., Murray, A., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08956-y · Cited by 1
Joint modeling of an outcome variable and integrated omics datasets using GLM-PO2PLS
Gu, Z., Uh, H., Houwing‐Duistermaat, J. J., & el Bouhaddani, S. (2024) · Journal of Applied Statistics · doi:10.1080/02664763.2024.2313458 · Cited by 1
Modeling Down Syndrome Neurodevelopment with Dosage Compensation
Czerminski, J. T. (2019) · eScholarship@UMassChan · doi:10.13028/j7xf-1q21 · Cited by 1
Restoring DSCAM expression rescues neuronal morphology and axon guidance deficits in Down syndromePreprint
Agrawal, M., Kirkise, N., Rygel, K., Sahoo, P. K., Vincent, C. J., Joyner, D., Aguilar-Alvarez, R., Philip, T. R., Dhillon, P. S., Patel, J., et al. (2025) · bioRxiv · doi:10.1101/2025.07.25.666804 · Cited by 1
Zhu, X., Haure‐Mirande, J., Bicak, M., Dong, P., Kruglikov, I., Al-subaie, A., Fossati, V., Noggle, S., Gandy, S., & Ehrlich, M. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.28.679053 · Cited by 1
Gene-dosage imbalance and altered neurogenesis in Down syndrome
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00006-5
Cazareth, J., Jarjat, M., Brau, F., Bardoni, B., & Maurin, T. (2022) · Neuromethods · doi:10.1007/978-1-0716-2569-9_4
Realizing the potential of exploiting human IPSCs and their derivatives in research of Down syndrome
Wang, Y., Ni, J., LIU, Y., Liao, D.-Y., Zhou, Q., Ji, X., NIU, G., & Ni, Y. (2023) · Biocell · doi:10.32604/biocell.2023.043781
Self-citationJandy, M., Hu, H., Liu, Y., & Bhattacharyya, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-78611-2_7
Self-citationBartesaghi, R., Chen, X., Johnstone, A. D., Das, U., & Mobley, W. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-89307-0_19
Metadata
- Authors
- Huo, H.-Q., Qu, Z.-Y., Yuan, F., Ma, L., Yao, L., Xu, M., Hu, Y., Ji, J., Bhattacharyya, A., Zhang, S.-C., & Liu, Y.
- Affiliations
- State Key Laboratory of Reproductive Medicine (CN)
- Shanghai Medical College of Fudan University (CN)
- University of Wisconsin–Madison (US)
- Nanjing Medical University (CN)
- Jiangsu Province Hospital (CN)
- University of Wisconsin System (US)
- Corresponding author
- Zhang, Su-Chun
- Liu, Yan
- Venue
- Stem Cell Reports
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 10
- Issue
- 4
- Pages
- 1251-1266
- ISSN
- 2213-6711 (ISSN-L)
- PMC
- PMC5998838
- OpenAlex
- W2789849905
- Cited by
- 122
- References
- 47
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 15 · 2023: 14 · 2022: 20 · 2021: 27 · 2020: 8 · 2019: 13 · 2018: 3
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Stem Cell Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (MH100031, MH099587, R21HD085288)
- National Basic Research Program of China (2016YFC1306703)
- Government of Jiangsu Province
- National Natural Science Foundation of China (BK20160044, BK20160047, 81471301)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- Down syndrome, GABAergic interneurons, neuronal migration, iPSC-derived neurons, calretinin, calbindin, cerebral cortex, hippocampus, cell morphometry
- MeSH terms
- Animals, Brain, Cell Differentiation, Cell Movement, Cell Survival, Down Syndrome, Gene Expression Regulation, Humans, Interneurons, Models, Biological, Somatostatin, Neurites, Gene Expression Profiling, Cell Shape, Actin Depolymerizing Factors, Mice, p21-Activated Kinases, Induced Pluripotent Stem Cells, Neural Stem Cells, GABAergic Neurons, Calbindin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review